Got a letter yesterday that Optum Rx, my Medicare prescription plan, will no longer cover my Lynparza med. Have been on it for almost 2 years with no out of pocket costs, and has been very effective in controlling my PSA. Now I will apparently be subject to a retail price of over $13,000 per month???? How in the world is anyone expected to afford that? And even after recent FDA approval? Can't believe it.
Astra Zeneca does offer a subsidy program for patients whose joint income is less than $82,300 per year. I will pursue it.
Written by
HopingForTheBest1
To view profiles and participate in discussions please or .
Would you consider trying the other FDA approved PARP inhibitor: rucaparib?
What about switching to Nubequa?
I hope you find an acceptable resolution to your problem.I had a bad experience with Optum. They really dragged their feet on approving eligard for my treatment. I had to get on the phone for more than an hour with my medicare plan F provider to resolve the issue. There was absolutely no reason or excuse for their lack of action. It left a bad impression. I will never select Optum in the future, ever.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.